Logos Global Management LP
- SEC CIK
- 0001792126
- Latest filing
- Aug 14, 2026
LCTX holding history
Lineage Cell Therapeutics, Inc. in every 13F filed by Logos Global Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LCTX overviewAll 13F holders of LCTXFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −5,000,000−100.0% | Sold out | Holders |
| Q3 2024 | 5,000,000 | $4.53M | 0.5% | +300,000+6.4% | Added | Holders |
| Q2 2024 | 4,700,000 | $4.69M | 0.5% | −1,550,000−24.8% | Reduced | Holders |
| Q1 2024 | 6,250,000 | $9.25M | 1.0% | +6,250,000 | New | Holders |